TP53 and small cell lung carcinoma: Overall, this pattern was similar to that reported by Pleasance et al[30].The previously described TP53 splice acceptor disrupt and RB1 C706F point mutation, characteristic of SCLC, [30], were detected both in the cell line and xenograft samples.